SOPHARMA AD (76/2022) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 28 September 2022.
Report no 76/2022
- 29.09.2022, 13:48
- Kategoria: Biznes i finanse
- Źródło: ESPI
Sopharma AD-BG11SOSOBT18-SOPHARMA
-
SOPHARMA AD (75/2022) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 26 September 2022.
Report no 75/2022- 29.09.2022, 10:35
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (74/2022) Shareholding notification from "Telso" AD
Report no 74/2022- 29.09.2022, 08:43
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (73/2022) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 27 September 2022.
Report no 73/2022- 28.09.2022, 13:30
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (70/2022) Sales revenues for August 2022
Report no 70/2022- 07.09.2022, 13:48
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (69/2022) Consolidated financial report according to IFRS as at 30 June 2022
Report no 69/2022- 29.08.2022, 13:22
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (68/2022) Results from the public offering to the shareholders of Sopharma properties REIT
Report no 68/2022- 26.08.2022, 09:50
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (67/2022) Sales revenues for July 2022
Report no 67/2022- 05.08.2022, 13:01
- Kategoria: Biznes i finanse
- Źródło: ESPI
